Biological Products, (No Diagnostic Substances) · DE · CIK 882095
Gilead Sciences discovers, develops, and delivers innovative medicines to prevent and treat life-threatening diseases like HIV, viral hepatitis, COVID-19, and cancer
Comparable business profile · signals at a glance
In the 90 days to Mar 27, 2026: 4 sold $45.4M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 27, 2026 | O'Day Daniel PatrickChairman & CEO | Sell | 10,000 | $136.82 | $1.4M |
| Mar 16, 2026 | Mercier JohannaChief Comm & Corp Aff Officer | Sell | 3,000 | $144.23 | $433K |
| Mar 16, 2026 | Dickinson Andrew DChief Financial Officer | Sell | 3,000 | $144.23 | $433K |
| Feb 27, 2026 | O'Day Daniel PatrickChairman & CEO | Sell | 6,419 | $145.18 | $932K |
| Feb 27, 2026 | O'Day Daniel PatrickChairman & CEO | Sell | 3,481 | $144.04 | $501K |
| Feb 27, 2026 | O'Day Daniel PatrickChairman & CEO | Sell | 100 | $145.71 | $15K |
| Feb 17, 2026 | Mercier JohannaChief Comm & Corp Aff Officer | Sell | 18,405 | $154.18 | $2.8M |
| Feb 17, 2026 | Mercier JohannaChief Comm & Corp Aff Officer | Sell | 9,395 | $154.91 | $1.5M |
| Feb 17, 2026 | Dickinson Andrew DChief Financial Officer | Sell | 3,000 | $154.43 | $463K |
| Feb 17, 2026 | Mercier JohannaChief Comm & Corp Aff Officer | Sell | 200 | $155.62 | $31K |
| Feb 5, 2026 | O'Day Daniel PatrickChairman & CEO | Sell | 115,640 | $150.00 | $17.3M |
| Jan 28, 2026 | O'Day Daniel PatrickChairman & CEO | Sell | 5,032 | $139.54 | $702K |
| Jan 28, 2026 | O'Day Daniel PatrickChairman & CEO | Sell | 4,968 | $140.24 | $697K |
| Jan 23, 2026 | O'Day Daniel PatrickChairman & CEO | Sell | 115,640 | $135.00 | $15.6M |
| Jan 20, 2026 | Bluestone JeffreyDirector | Sell | 5,000 | $123.50 | $618K |
| Jan 15, 2026 | Dickinson Andrew DChief Financial Officer | Sell | 3,000 | $124.31 | $373K |
| Jan 15, 2026 | Mercier JohannaChief Commercial Officer | Sell | 3,000 | $124.31 | $373K |
| Dec 29, 2025 | O'Day Daniel PatrickChairman & CEO | Sell | 10,000 | $124.83 | $1.2M |
| Dec 15, 2025 | Mercier JohannaChief Commercial Officer | Sell | 3,000 | $122.00 | $366K |
| Dec 15, 2025 | Dickinson Andrew DChief Financial Officer | Sell | 3,000 | $122.00 | $366K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Coverage (30d): 8 reputable articles · skews ▼ negative.
Reputable outlets only (Reuters, WSJ, CNBC, Barron's, and peers). More on Google News ↗